Filing Details
- Accession Number:
- 0001104659-24-013558
- Form Type:
- 13G Filing
- Publication Date:
- 2024-02-11 19:00:00
- Filed By:
- Rubric Capital Management
- Company:
- Orthofix Medical Inc. (NASDAQ:OFIX)
- Filing Date:
- 2024-02-12
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Rubric Capital Management | 0 | 3,665,000 | 0 | 3,665,000 | 3,665,000 | 9.97 % |
| David Rosen | 0 | 3,665,000 | 0 | 3,665,000 | 3,665,000 | 9.97 % |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Orthofix Medical Inc.
(Name of Issuer)
Common Stock, $0.10 par value per share
(Title of Class of Securities)
68752M108
(CUSIP Number)
December 31, 2023
(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
| x | Rule 13d-1(b) |
| ¨ | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
(Page 1 of 8 Pages)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)
CUSIP No. 68752M108
| 13G | Page 2 of 8 Pages |
| 1 | NAMES OF REPORTING PERSONS Rubric Capital Management LP
| ||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ¨ (b) ¨ | |
| 3 | SEC USE ONLY
| ||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware
| ||
| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER 0
| |
| 6 | SHARED VOTING POWER 3,665,000 shares of Common Stock
| ||
| 7 | SOLE DISPOSITIVE POWER 0
| ||
| 8 | SHARED DISPOSITIVE POWER 3,665,000 shares of Common Stock
| ||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,665,000 shares of Common Stock
| ||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
| ¨ | |
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.97%
| ||
| 12 | TYPE OF REPORTING PERSON PN, IA
| ||
CUSIP No. 68752M108
| 13G | Page 3 of 8 Pages |
| 1 | NAMES OF REPORTING PERSONS David Rosen
| ||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) ¨ (b) ¨ | |
| 3 | SEC USE ONLY
| ||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION United States of America
| ||
| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER 0
| |
| 6 | SHARED VOTING POWER 3,665,000 shares of Common Stock
| ||
| 7 | SOLE DISPOSITIVE POWER 0
| ||
| 8 | SHARED DISPOSITIVE POWER 3,665,000 shares of Common Stock
| ||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,665,000 shares of Common Stock
| ||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
| ¨ | |
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.97%
| ||
| 12 | TYPE OF REPORTING PERSON IN
| ||
CUSIP No. 68752M108
| 13G | Page 4 of 8 Pages |
| Item 1(a). | NAME OF ISSUER: |
| The name of the issuer is Orthofix Medical Inc. (the "Issuer"). |
| Item 1(b). | ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: |
| The Issuer's principal executive offices are located at 3451 Plano Parkway, Lewisville, Texas 75056. |
| Item 2(a). | NAME OF PERSON FILING: | |
| This statement is filed by: | ||
| (i) | Rubric Capital Management LP ("Rubric Capital"), the investment adviser to certain investment funds and/or accounts (collectively, the "Rubric Funds") that hold the shares of Common Stock (as defined in Item 2(d) below) reported herein; and | |
| (ii) | David Rosen ("Mr. Rosen"), Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital. | |
| The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." | ||
| The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein. | ||
| Item 2(b). | ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: |
| The address of the principal business office of each of the Reporting Persons is 155 East 44th St, Suite 1630, New York, NY 10017. |
| Item 2(c). | CITIZENSHIP: |
| Rubric Capital is a Delaware limited partnership. Mr. Rosen is a citizen of the United States of America. |
| Item 2(d). | TITLE OF CLASS OF SECURITIES: |
| Common stock, $0.10 par value per share (the "Common Stock"). |
| Item 2(e). | CUSIP NUMBER: |
| 68752M108 |
CUSIP No. 68752M108
| 13G | Page 5 of 8 Pages |
| Item 3. | IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: |
| (a) | ¨ | Broker or dealer registered under Section 15 of the Act, | |
| (b) | ¨ | Bank as defined in Section 3(a)(6) of the Act, | |
| (c) | ¨ | Insurance Company as defined in Section 3(a)(19) of the Act, | |
| (d) | ¨ | Investment Company registered under Section 8 of the Investment Company Act of 1940, | |
| (e) |